Report #2842513

Received May 23, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (NO BRAND NAME)	UNKNOWN MANUFACTURER	UNK	UNK	—

Symptoms (1)

Injection site erythema

Symptom narrative

the redness from my injection site is spreading; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of injection site erythema in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced injection site erythema (Verbatim: the redness from my injection site is spreading). The outcome of the injection site erythema was not reported. Additional Information: GSK Receipt Date: 20-MAY-2025 It was reported that redness from his/her injection site had spread.